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Abstract
Background Cardiac rehabilitation (CR) has favourable
effects on cardiovascular mortality and morbidity.
Therefore, it might reasonable to expect that incom-
plete CR participation will result in suboptimal patient
outcomes.
Methods We studied the 914 post-acute coronary syn-
drome patients who participated in the OPTImal CAr-
diac REhabilitation (OPTICARE) trial. They all started
a ‘standard’ CR programme, with physical exercises
(group sessions) twice a week for 12 weeks. Incom-
plete CR was defined as participation in <75% of the
scheduled exercise sessions. Patients were followed-
up for 2.7 years, and the incidence of cardiac events
was recorded. Major adverse cardiac events (MACE)
included all-cause mortality, non-fatal myocardial in-
farction and coronary revascularisation.
Results A total of 142 (16%) patients had incomplete
CR. They had a higher incidence of MACE than their
counterparts who completed CR (11.3% versus 3.8%,
adjusted hazard ratio [aHR] 2.86 and 95% confidence
interval [CI] 1.47–5.26). Furthermore, the incidence
of any cardiac event, including MACE and coronary
revascularisation, was higher (20.4% versus 11.0%,
aHR 1.54; 95% CI 0.98–2.44). Patients with incom-
plete CR were more often persistent smokers than
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those who completed CR (31.7% versus 11.5%), but
clinical characteristics were similar otherwise.
Conclusion Post-ACS patients who did not complete
a ‘standard’ 12-week CR programme had a higher
incidence of adverse cardiac events during long-term
follow-up than those who completed the programme.
Since CR is proven beneficial, further research is
needed to understand the reasons why patients ter-
minate prematurely.
Keywords Acute coronary syndrome · Lifestyle ·
Cardiac rehabilitation
Introduction
Cardiac Rehabilitation (CR) is a class I recommended
intervention in patients with coronary artery disease
and has beneficial effects on physical fitness, qual-
ity of life, cardiovascular risk factors and clinical out-
come, including mortality [1–5]. Despite the evidence
of these beneficial effects, CR programmes are still
largely underutilised [6]. What’s more, a substantial
number of patients that do participate in CR attend
only a few sessions and then drop out prematurely.
It might reasonably be expected that such subopti-
mal CR participation will in less favourable results as
What’s new?
 During a follow-up of 3 years, occurrence of ma-
jor adverse cardiac events (MACE) was higher in
patients with acute coronary syndrome who did
not complete cardiac rehabilitation compared
with those who did.
 Patients with incomplete cardiac rehabilitation
were more often persistent smokers than those
who did complete cardiac rehabilitation.
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well. Suaya and Beauchamp were the first to describe
a possible relation between the number of sessions
attended and mortality [7, 8]. In more recent studies
such a relation was also found in specific populations,
including diabetic patients and women with coronary
artery disease [9, 10]. However, contradictory findings
of CR results were also reported [11], which may be
caused by the lack of a unanimous definition of CR
‘participation’ and ‘completion’. For example, in sev-
eral studies the attendance of at least one session was
already regarded as CR participation [12, 13], whereas
others used a more stringent definition [7, 8].
Recently, we presented the OPTImal CArdiac REha-
bilitation (OPTICARE) trial; a randomised controlled
CR trial that enrolled 914 patients post acute coronary
syndrome (ACS) [14, 15]. All patients started a ‘stan-
dard’ 12-week CR programme, and we aimed to assess
an association between completion of the programme
and incidence of adverse cardiac events during pro-
longed follow-up. Furthermore, we looked for possi-
ble determinants of CR completion. For the current
analysis, CR is defined as ‘complete’ if the participant
attended at least 75% of the physical programme, and
‘incomplete’ if otherwise.
Material and methods
Patients
OPTICARE was an open, randomised, controlled trial
that studied the effects of intensified and prolonged
CR compared with standard CR on cardiac risk pro-
file, levels of daily physical activity, quality of life and
health care consumption in patients after ACS. Details
on inclusion and exclusion criteria and study proce-
dures are described in the OPTICARE design paper
[14]. Briefly, 914 patients who were discharged after
ACS admission were scheduled to receive ‘standard’
CR (see below) for 12 weeks according to the European
Society of Cardiology (ESC) guidelines [16]. A total of
608 patients were randomised to receive extended CR
with extra behavioural counselling in individual tele-
phone sessions or group sessions until 9 months af-
ter completion of standard CR. The primary outcome
was the SCORE (Systematic COronary Risk Evalua-
tion) 10-year cardiovascular mortality risk function at
18 months after the index ACS. Results of OPTICARE
showed no additional benefits with respect to SCORE
in patients randomised to extended CR [15]. Patients
largely reached target levels of modifiable risk factors
already following standard CR. Therefore, for the pur-
pose of the current analysis, all OPTICARE patients
were analysed as a homogeneous cohort. The study
was performed according to the CONSORT guidelines.
The study was conducted according to the Helsinki
Declaration and the study was approved by the Medi-
cal Ethics Committee of the Erasmus MC. All patients
consented to participation in this study.
CR according to the Capri programme
CR was offered by Capri Cardiac Rehabilitation (Capri
CR) at eight different locations in the cities of Rot-
terdam and The Hague with referrals from 10 hospi-
tals in the broader Rotterdam/The Hague region. The
core of the Capri CR programme is 1.5-hour group
exercise sessions twice weekly. Besides the exercise
programme, verbal and written instructions are given
on how to deal with exercise, diet, smoking cessa-
tion and stress management. The aim of the pro-
gramme is to improve adherence to lifestyle modifi-
cation, and to help patients to adopt a positive role in
the care of their own health. If necessary, individual
consultations with a psychiatrist, psychologist, social
worker and dietician are provided. A multidisciplinary
team, led by a physician, specialised physiotherapists,
nurses and social workers, together with the patient,
determined the exact length of a CR programme with
an average duration of 12 weeks. Upon completion of
the CR programme, a maximum (symptom-limited)
bicycle stress test is performed.
For the current analysis, CR is defined as ‘complete’
if the participant attended at least 75% of the physical
programme, and ‘incomplete’ otherwise [8].
Data collection
Data were collected on demographic variables, car-
diovascular risk factors and cardiovascular history.
Data on cardiovascular risk factors were measured,
as these were part of the OPTICARE study endpoint
(SCORE). Systemic arterial hypertension was defined
as a systolic blood pressure >140mmHg and/or di-
astolic blood pressure >90mmHg, or treatment for
hypertension. Hypercholesterolaemia was defined as
a total cholesterol >6.0mmol/l or treatment for hy-
percholesterolaemia before index event. Diabetes was
diagnosed as a fasting plasma glucose >7.0mmol/l
or the use of glucose-lowering therapy medication.
Smoking was defined as self-reported smoking at the
index ACS. At randomisation, self-reported smok-
ing cessation was verified by using a Smokerlyzer,
which measures the concentration of carbon monox-
ide in breath. Family history of premature coronary
artery disease was defined as a self-reported history
of any first-degree family member with a history of
myocardial infarction (MI), percutaneous coronary
intervention (PCI), or coronary artery bypass grafting
(CABG) before the age of 60 years.
Clinical endpoints
For the current analysis, clinical endpoints were col-
lected until DATE, which resulted in a median (IQR)
follow-up of 2.7 (range 2 years to 5 years) after the
index ACS. We defined the incidence of major ad-
verse cardiovascular events (MACE) as our primary
endpoint, which includes all-cause mortality, non-fa-
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Table 1 Patient characteristics in relation to completion and incompletion of CR
Complete CR Incomplete CR Odds ratio a (95% CI) P-value
No. of patients 770 142
Age, years 57.6 (9.1) 55.5 (10.8) 0.98 (0.96–0.99) 0.11
Man 623 (80.9) 114 (80.3) 0.96 (0.61–1.50) 0.86
Initial revascularisation treatment
PCI 600 (77.9) 112 (78.9) 1.06 0.68–1.63 0.80
CABG 3 (0.4) 2 (1.4) 3.65 0.60–22.05 0.13
No Revascularisation 167 (21.7) 28 (19.7) 1.10 0.71–1.72 0.74
Cardiovascular risk factors
Family history 409 (53.1) 71 (50.0) 0.88 (0.62–1.26) 0.50
Diabetes 102 (13.2) 19 (13.4) 1.01 (0.60–1.71) 0.96
Hypertension 319 (41.4) 55 (38.7) 0.89 (0.62–1.29) 0.55
Smoking
– Persistent 89 (11.5) 45 (31.7) 2.78 (1.70–4.55) <0.001
– Never 461 (59.9) 57 (40.1) 0.68 (0.44–1.05) 0.082
– Quit (reference) 220 (28.5) 40 (28.1) 1
Hypercholesterolaemia 268 (34.8) 44 (31.0) 0.84 (0.57–1.23) 0.38
Cardiovascular history 129 (16.8) 33 (23.2) 1.50 0.97–2.31 0.14
MI 63 (8.2) 17 (12.0) 1.53 0.86–2.69 0.14
PCI 72 (9.4) 17 (12.0) 1.32 0.75–2.31 0.33
CABG 9 (1.2) 4 (2.8) 2.45 0.74–8.07 0.13
CVA 3 (0.4) 2 (1.4) 3.65 0.60–21.05 0.13
TIA 15 (1.9) 4 (2.8) 145 0.48–4.46 0.50
Cardiac medication
Anticoagulants 766 (99.4) 139 (97.9) NA 0.68
Statins 740 (96.1) 128 (90.1) 0.42 0.20–0.88 0.017
ACE inhibitors 545 (70.8) 87 (61.3) 0.68 0.46–0.99 0.046
Beta blockers 634 (82.3) 113 (79.6) 0.91 0.57–1.45 0.69
Continuous data are presented as mean (standard deviation) values, and categorical data are presented as numbers (percentages)
ACE angiotensin-converting enzyme, CABG coronary artery bypass grafting, CI confidence interval, CR cardiac rehabilitation, CVA cerebrovascular accident,
MI myocardial infarction, PCI percutaneous coronary intervention, TIA transient ischaemic attack
a Odds ratio related with the characteristic for incompletion of the cardiac rehabilitation program
tal MI and coronary revascularisation. We also col-
lected data on other cardiovascular events, including
hospitalisation for unstable angina (chest pain in rest
with negative biomarkers but positive stress testing),
stable angina (chest pain on exertion with negative
biomarkers), non-specific chest pain (chest pain in
rest with negative biomarkers and negative or absent
stress testing), cardiac arrhythmia’s and heart failure.
We also counted cardiac emergency room visits with-
out hospitalisation. All clinical endpoints were veri-
fied by an independent Clinical Event Committee.
Statistical analysis
Continuous variables were presented as mean (stan-
dard deviation), whereas categorical variables are
expressed as numbers and percentages. Comparisons
between patients with and without completed CR
were performed by the Student’s t-test for continuous
variables, and Pearson’s chi-squared test or Fisher’s
exact tests, for categorical variables.
The cumulative incidence of the clinical end-
points over time was studied using the Kaplan-Meier
method, whilst log-rank tests were applied to evaluate
differences between patients with and without com-
pleted CR. Patients lost to follow-up were considered
at risk until the date of last contact, at which point
they were censored.
Cox regression analyses were performed to further
study whether or not completing the programme was
associated with the incidence of study endpoints. We
ran univariable models, and multivariable models
with adjustment for outcome determinants and po-
tential confounders. In view of the number of MACE
(N= 45, see Results section) in the corresponding
MACE model, we decided to adjust only for age, gen-
der, diabetes, prior history of cardiovascular events,
and randomly allocated study treatment, in order to
avoid model overfitting [17]. With respect to any car-
diovascular events, we adjusted for age, gender, prior
cardiovascular event, diabetes, hypertension, familial
history, smoking, hypercholesterolaemia and study
treatment. Findings are presented as crude hazard
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Table 2 Cardiovascular events after CR
Complete CR Incomplete CR P-Value
No. of patients 770 142
Any MACE 29 (3.8) 16 (11.3)
– Mortality 8 (1.0) 4 (2.8) 0.089
– ST-elevation MI 7 (0.9) 2 (1.4) 0.58
– Non-ST-elevation MI 10 (1.3) 4 (2.8) 0.17
– CABG 4 (0.5) 2 (1.4) 0.23
– PCI 9 (1.1) 9 (6.3) 0.003
Any non-major cardiovascular events 85 (11.0) 29 (20.4)
– Hospitalisation because of
– Unstable angina 4 (0.5) 2 (1.4) 0.23
– Stable angina 19 (2.5) 8 (5.6) 0.039
– Non-specific chest pain 17 (2.2) 6 (4.2) 0.16
– Arrhythmias 12 (1.5) 1 (0.7) 0.48
– Heart failure 0 (0.0) 0 (0.0) –
– Cardiac emergency room visit without hospitalization 38 (4.9) 11 (7.7) 0.17
Data are presented as numbers (percentages)
CABG coronary artery bypass grafting, CR cardiac rehabilitation, CVA cerebrovascular accident, MACE major adverse cardiac event, MI myocardial infarction,
PCI percutaneous coronary intervention
ratios (HR) and adjusted hazard ratios (aHR) with 95%
confidence intervals (CI).
Logistic regression analyses were performed to
identify factors that were associated with CR incom-
pletion. We considered the following factors: age, sex,
prior cardiovascular event, diabetes, hypertension,
family history of premature coronary artery disease,
smoking and hypercholesterolaemia. Findings are
presented as odds ratios (OR) with 95% CI.
All statistical tests were two-tailed and a p-value of
<0.05 was considered statistically significant. Statisti-
cal analysis was performed with SPSS 24 for Windows
(SPSS Inc., Chicago, Il, USA).
Results
Patient characteristics
In total, 770 (84%) patients completed CR, and 142
patients (16%) did not. Patients who completed CR
had, on average, 23 exercise sessions, as compared
with 6 sessions for those who did not complete CR
(p-value <0.001). Patients with and without CR com-
pletion had similar baseline characteristics, except for
smoking, and the use of statins and angiotensin-con-
verting enzyme inhibitors: those who did not com-
plete CR were more often persistent smokers (31.7%
versus 11.5%, p-value <0.001) (Tab. 1).
CR incompletion and clinical endpoints
Forty-five patients (4.9%) had at least one MACE
(Tab. 2). The incidence of MACE was higher in the
patients who had incomplete CR than in their coun-
terparts who completed the programme (11.3% versus
3.8%; HR 2.94 and 95% CI 1.59–5.55). After adjust-
ment for multiple factors (see Methods section), this
relation remained significant (aHR 2.86 and 95% CI
1.47–5.26).
In total, 114 patients (12.5%) suffered from one or
more cardiovascular events (Tab. 2). The cumulative
incidence of any cardiovascular event at 4 years in
complete CR versus incomplete CR was 18% and 25%
according to the Kaplan-Meier method, respectively
(log-rank p= 0.006) (Fig. 1). Incomplete CR was associ-
ated with a higher incidence of cardiovascular events
(HR 1.69; 95% CI 1.11–2.56). Again, after adjustment
for multiple factors, this relation remained, although
our criterion for statistical significance was not met
(HR 1.54; 95% CI 0.98–2.44).
MACE during CR was not the reason for incomplete
CR, as all 5 patients with MACE during CR ultimately
completed CR after a new coronary intervention.
Fig. 1 Cumulative incidence of any cardiovascular event.
CR cardiac rehabilitation
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Predictors of incomplete CR
Persistent smokers had 2.78 times higher odds of in-
complete CR than those who quitted smoking since
the ACS admission (OR 2.78 and 95% CI 1.70–4.55, p-
value <0.001) (Tab. 1). Never-smokers tended to have
lower odds of incomplete CR than quitters, but this
difference was statistically non-significant. We could
not identify any other characteristic that (independent
of smoking behaviour) related with higher or lower
odds of incomplete CR. The C-index of the logistic
regression model that related smoking behaviour to
completion of the CR programme was 0.63. Thus, pa-
tients could not satisfactorily be identified as either
completers or non-completers on the basis of their
smoking behaviour alone.
Discussion
We found that post-ACS patients who did not com-
plete CR—defined as participation of at least 75% of
the sessions—had an almost threefold higher inci-
dence of MACE during prolonged follow-up. We fur-
ther found that smoking behaviour was associated
with the degree of CR completion—smoking cessation
was a success factor. Still, the reasons why patients did
not complete the 12-week ‘standard’ CR programme
remained largely unknown.
Duration and intensity of CR programmes are
highly variable [18]. In a systematic review of Rauch
et al. [19] no comparison could be made between
beneficial effects and the type or length of CR of-
fered, given the wide heterogeneity of CR programmes
which varied both in duration (3 weeks to 12 months)
and intensity (2 to 5 sessions per week). Not sur-
prisingly therefore, a definition of ‘complete CR’ is
absent in the guidelines of the European Association
for Cardiovascular Prevention & Rehabilitation [20]
both in terms of length of a standard programme
and in particular in terms of the number of attended
sessions. Unfortunately, completion is not defined
at all in most studies [12], whereas in other studies
it ranged from minimal attendance of one session
[13], to 50% in EUROASPIRE IV [21], and to 75% in
the study of Beauchamp et al. [8]. We used the most
stringent Beauchamp criterion, because in our opin-
ion CR will only be effective if the absenteeism is
minimal. This position is supported by our data, as
incomplete CR according to Beauchamp was a strong
and independent predictor of increased risk for car-
diovascular events. It should be noticed that the
majority of patients in the incomplete CR group quit-
ted CR very early in the programme, resulting in an
important difference in attended sessions: on average
6 versus 23 sessions. Patients who attended a number
of sessions in-between were a minority. Therefore, in
our opinion, the minimal number of sessions should
be the chosen >75% of the physical programme, even
though this is an arbitrary choice. In contrast to what
one might expect, the occurrence of MACE during CR
was not the reason for incomplete CR, as all 5 patients
with MACE during CR ultimately completed CR after
a new coronary intervention.
Benefits of complete versus incomplete CR were
shown in a few retrospective studies. In 2009 Suaya
et al. [7] was the first to show a relation between mor-
tality and less than 25 attended CR sessions in elderly
with coronary artery disease. Subsequently, these re-
sults were confirmed by a study of Beauchamp et al.
in which patients who suffered from an acute myocar-
dial infarction or who underwent PCI and attended
less than 25% of the CR sessions had a more than
two-fold increased mortality risk during 14-year fol-
low-up, compared with those attended >75% of the
sessions [8]. More recently, Armstrong et al. reported
in a large study in almost 3000 diabetic patients, in-
cluded between 1996 to 2010, that diabetic patients
were less likely to start and to complete CR [9]. Al-
though complete CR was not well defined, patients
who fully participated in the 12-week CR programme
had reduced mortality and hospitalisation in com-
parison with CR participants who did not complete
CR. Finally, in a large study by Colbert et al. in over
6000 women with at least one-vessel coronary artery
disease who participated in CR in 1996, complete CR,
defined as at least 12 of 24 CR sessions (50%) including
a 12-week post-CR assessment, had the lowest mor-
tality during long-term follow-up [10].
In a recent retrospective study of our group we
already demonstrated a reduction in 10-year mortal-
ity in ACS patients. We studied 1159 ACS patients
who had primary PCI. We found that patients who at-
tended a CR programme had a significantly lower 10-
year mortality than their no-CR counterparts (14.7%
versus 23.5%), and that patients who completed CR
had a lower 10-year mortality compared with patients
who started CR but did not complete the programme
(13.6% versus 18.9%) [22]. The current study differs
from the ones mentioned, because: 1) our patients
constituted a more homogeneous population with
ACS in the large majority treated with primary PCI;
2) medical therapy was more intense; and 3) medi-
cal therapy did not differ between the patients with
complete and incomplete CR.
Since incompleteness of CR is associated with clin-
ical outcome, it seems important that we identify pa-
tients at risk for drop-out. The single most important
predictor for incompleteness of CR was smoking per-
sistence. Other authors have also shown that smok-
ing is an important predictor for incompletion of CR
[23]. We can only speculate why. Patients are moti-
vated but may simply not be able to quit for whatever
reason. However, patients who are not motivated to
quit smoking may also not be motivated to work on
a healthier lifestyle in general either. It could also be
that smoking is just part of other patient characteris-
tics, such as a certain type of personality, limited edu-
cation, and lower socio-economic status [24]. Patients
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do not always see the relevance of quitting smok-
ing, which suggests that our efforts to educate society
about the negative influence of smoking is still not
optimal. Another explanation might be that smokers
feel stigmatised and isolated during CR as suggested
by Beauchamp et al. [8]. Importantly, many authors
warn that we should interpret the results of studies on
smoking with caution, since in most studies ‘smoking’
was poorly defined [24]. Studies often relied on hospi-
tal records or self-reporting, without biochemical ver-
ification as we did in our current study. Since stop
smoking rates are even lower when verified by objec-
tive biochemical verification we plea to continue this
measurement in the future.
Since these were patients included in the OPTI-
CARE trial, a potential bias from patients’ willingness
to participate in a trial may exist. Certainly, the
number of patients that drop-out may be higher in
routine clinical care settings. Whether these patients
have a different profile and/or cardiac outcome is not
known. Also, our study population was at a relatively
‘low risk’ for drop-out, with relatively young patients
without heart failure or renal impairment. Another
limitation is that we do not know the reasons behind
incomplete CR. From our own daily experience we
know that this could be a wide variety of reasons,
both medical and non-medical.
Finally, it is difficult to define what exactly con-
stitutes ‘complete CR’ as it comprises a multidisci-
plinary programme, including exercise sessions, diet,
smoking cessation and stress management courses.
Each individual patient has different needs of atten-
tion, for instance attending dietary advise sessions
may be more important for an obese diabetic patient
than for a non-obese non-diabetic patient. All studies
up to now focus on the number of exercise sessions:
the effects of the other multidisciplinary sessions are
still unknown and were therefore not incorporated in
the current definition of complete CR. Future studies
should address the importance of attending the non-
exercise sessions.
Conclusion
Post-ACS patients who did not complete a ‘standard’
12-week CR programme had a higher incidence of ad-
verse cardiac events during long-term follow-up than
their counterparts who completed the programme.
Persistent smokers are at risk of non-completion,
which is, indirectly, an extra argument to motivate
patients to quit smoking. Still, patients could not sat-
isfactorily be identified as potential non-completers
on the basis of their smoking behaviour alone. As CR
is proven to be beneficial, further research is needed
to understand the reasons why patients terminate
prematurely.
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